Sales & Marketing News | pharmaphorum

News

Novo Nordisk taps brakes on Wegovy as demand soars

Novo Nordisk has said it will temporarily reduce production of the lower starting doses of its weight-loss drug Wegovy, as demand for the therapy continues to challenge it

News

J&J sets top price for consumer health unit Kenvue’s IPO

Johnson & Johnson’s consumer health unit Kenvue looks set to raise $3.8 billion in an upsized initial public offering (IPO), valuing the business at around $41 billion

News

Otsuka’s lupus nephritis drug Lupkynis backed for NHS use

Patients in England and Wales with active lupus nephritis will soon be able to access treatment with Otsuka Pharma’s Lupkynis following a recommendation by the health tech

News

Wave of strikes hit GSK’s UK manufacturing

GSK was able to avert industrial action at some of its UK facilities last year after agreeing a

News

Gilead and US Government square up in court over PrEP

Gilead Sciences will go to court this week to argue that it does not need to pay the US Government a share of the profits it has made on the use of its HIV drugs for pre-e

News

Takeda tries again with subcutaneous Entyvio

More than three years after it was first rejected by the FDA, Takeda's subcutaneous (SC) formulation of Entyvio has been resubmitted as a maintenance therapy for ulcerativ

Novo Nordisk taps brakes on Wegovy as demand soars

J&J sets top price for consumer health unit Kenvue’s IPO

Otsuka’s lupus nephritis drug Lupkynis backed for NHS use

Wave of strikes hit GSK’s UK manufacturing

Gilead and US Government square up in court over PrEP

Takeda tries again with subcutaneous Entyvio

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks